Alex Pasteur
Non Executive Director
PeptoneLondon, England, United Kingdom
14 investmentsAlex Pasteur is a Non Executive Director at Peptone based in London, England, United Kingdom. Alex Pasteur has backed 14 companies, including Pulmocide, Oviva and Adaptimmune. Investment focus areas include Health Care, Drug Discovery and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
Drug Discovery
Wellness
Enterprise Software
Android
Life Science
Engineering
Banking
Information Technology (IT)
Supercomputing
Finance
Software
Biotechnology
Drug Development
Electronic Health Records (EHR)
Health and Hospital Services
FinTech
Research
Reviews and Recommendations
Consumer Software
High-Performance Computing
Medical
Big Data
Information Technology
B2B
Media and Entertainment
Machine Learning
Pharmaceuticals
Portfolio Companies (15)
| 1 | Pulmocide |
| 2 | Oviva |
| 3 | Adaptimmune |
| 4 | Orchard Therapeutics (NASDAQ: ORTX) acquired by Kyowa Kirin in 2023 |
| 5 | Acacia Pharma (EURONEXT BRUSSELS: ACPH) acquired by Eagle Pharmaceuticals in 2022 |
| 6 | Genomics |
| 7 | Tenpoint Therapeutics |
| 8 | Ltd. |
| 9 | NodThera |
| 10 | Castor |
| 11 | Shift Bioscience |
| 12 | Arvelle Therapeutics (Acquired by Angelini Pharma in 2021) |
Showing 1–12 of 15
Page 1 of 2
Access Full Contact Information
Get Alex Pasteur's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.